CRN Team Parisiadou is studying how RNA damage and ribosomal dysfunction contribute to dopamine neuron vulnerability in #Parkinson’s.
By identifying early disease pathways, the team aims to uncover potential targets for new treatments.
🔗 bit.ly/4wEFiId
CRN Team Parisiadou is studying how RNA damage and ribosomal dysfunction contribute to dopamine neuron vulnerability in #Parkinson’s.
By identifying early disease pathways, the team aims to uncover potential targets for new treatments.
🔗 bit.ly/4wEFiId
By examining why some brain cells withstand disease better, the team aims to uncover ways to protect neurons and slow Parkinson’s progression.
bit.ly/4xTjiKM
By examining why some brain cells withstand disease better, the team aims to uncover ways to protect neurons and slow Parkinson’s progression.
bit.ly/4xTjiKM
CRN Team Keller is studying the molecular mechanisms linking aging and Parkinson's across brain cell types, sexes, and species.
Using multi-omics, machine learning, and functional genomics, the team aims to identify key genes and small RNAs that drive disease.
🔗 bit.ly/3SnfBhu
CRN Team Keller is studying the molecular mechanisms linking aging and Parkinson's across brain cell types, sexes, and species.
Using multi-omics, machine learning, and functional genomics, the team aims to identify key genes and small RNAs that drive disease.
🔗 bit.ly/3SnfBhu
CRN Team Petrucelli is investigating molecular modifiers of co-pathologies in #Parkinsons disease.
Their work examines how alpha-synuclein, TDP-43, amyloid beta, and tau may interact to influence disease outcomes and progression.
🔗 bit.ly/3S6MleG
CRN Team Petrucelli is investigating molecular modifiers of co-pathologies in #Parkinsons disease.
Their work examines how alpha-synuclein, TDP-43, amyloid beta, and tau may interact to influence disease outcomes and progression.
🔗 bit.ly/3S6MleG
CRN Team Halliday is studying how molecular and cellular subtypes may shape #Parkinsons disease initiation and progression.
Their work uses global brain bank cohorts, AI, and advanced lab approaches to uncover biological drivers of disease heterogeneity.
🔗 bit.ly/4q5IyL9
CRN Team Halliday is studying how molecular and cellular subtypes may shape #Parkinsons disease initiation and progression.
Their work uses global brain bank cohorts, AI, and advanced lab approaches to uncover biological drivers of disease heterogeneity.
🔗 bit.ly/4q5IyL9
CRN Team Doxakis is studying how co-pathologies may drive #Parkinsons disease progression.
Their work examines how alpha-synuclein, tau, and TDP43 interactions may contribute to neurodegeneration and clinical heterogeneity.
🔗 bit.ly/45yo7gh
CRN Team Doxakis is studying how co-pathologies may drive #Parkinsons disease progression.
Their work examines how alpha-synuclein, tau, and TDP43 interactions may contribute to neurodegeneration and clinical heterogeneity.
🔗 bit.ly/45yo7gh
CRN Team Khurana, one of our new PD Heterogeneity teams, is studying how pesticide exposures may shape #Parkinsons biology and clinical subtypes.
Their work combines cohort data, stem-cell models, alpha-synuclein biomarkers, and AI tools.
🔗 bit.ly/4wVuHt4
CRN Team Khurana, one of our new PD Heterogeneity teams, is studying how pesticide exposures may shape #Parkinsons biology and clinical subtypes.
Their work combines cohort data, stem-cell models, alpha-synuclein biomarkers, and AI tools.
🔗 bit.ly/4wVuHt4
CRN Team Kirkeby, one of our new PD Heterogeneity teams, is connecting the environmental exposome to #Parkinsons risk and pathology.
Their work combines stem cell screening, exposomics, and Danish registry data to uncover toxicant-linked disease pathways.
🔗 bit.ly/4ym8wh6
CRN Team Kirkeby, one of our new PD Heterogeneity teams, is connecting the environmental exposome to #Parkinsons risk and pathology.
Their work combines stem cell screening, exposomics, and Danish registry data to uncover toxicant-linked disease pathways.
🔗 bit.ly/4ym8wh6
Finally back to Westerfolds Park for a Tuesday night lap with the crew
Finally back to Westerfolds Park for a Tuesday night lap with the crew
CRN Team Greenamyre is investigating how environmental toxicant exposures may trigger biological processes that drive neurodegeneration and contribute to #Parkinsons heterogeneity.
Their work could help identify targets for mitigating post-exposure toxicity.
🔗 bit.ly/4fmkSOS
CRN Team Greenamyre is investigating how environmental toxicant exposures may trigger biological processes that drive neurodegeneration and contribute to #Parkinsons heterogeneity.
Their work could help identify targets for mitigating post-exposure toxicity.
🔗 bit.ly/4fmkSOS
Meet Claudia and Penny, our newest Therapy Team! Penny loves chasing scents, her bestie Claudia, and her toy "PupSicle" 🍦 Oh, and if you happen to have a ham cube? You'll have a friend for life! 🐾
#HandInPaw #TeamTuesday
Meet Claudia and Penny, our newest Therapy Team! Penny loves chasing scents, her bestie Claudia, and her toy "PupSicle" 🍦 Oh, and if you happen to have a ham cube? You'll have a friend for life! 🐾
#HandInPaw #TeamTuesday
CRN Team Bronstein, one of our new PD Heterogeneity teams, is studying how environmental toxins and genetic factors may shape #Parkinsons progression.
Their work uses stem cells and animal models to examine vulnerability to faster progression.
🔗 bit.ly/4waZHVM
CRN Team Bronstein, one of our new PD Heterogeneity teams, is studying how environmental toxins and genetic factors may shape #Parkinsons progression.
Their work uses stem cells and animal models to examine vulnerability to faster progression.
🔗 bit.ly/4waZHVM
CRN Team Ulusoy, one of our new Tool Generation teams, is developing labeled antibodies to better detect and measure mitochondrial and oxidative stress pathways in #Parkinsons disease, improving how researchers visualize disease biology.
Follow the series👇
🔗 bit.ly/4nGXjD1
CRN Team Ulusoy, one of our new Tool Generation teams, is developing labeled antibodies to better detect and measure mitochondrial and oxidative stress pathways in #Parkinsons disease, improving how researchers visualize disease biology.
Follow the series👇
🔗 bit.ly/4nGXjD1
Thank you for your continued commitment to bringing comfort, connection, and encouragement to our community. 💛
#TeamTuesday #HandInPaw
Thank you for your continued commitment to bringing comfort, connection, and encouragement to our community. 💛
#TeamTuesday #HandInPaw
This week we introduce Lorenzo Mercuri, Post-Doctoral Researcher at the Sapienza University of Rome, Associate Researcher at the Laboratoire de médiévistique occidentale de Paris, and Co-Social Media Editor of the SSCLE.
This week we introduce Lorenzo Mercuri, Post-Doctoral Researcher at the Sapienza University of Rome, Associate Researcher at the Laboratoire de médiévistique occidentale de Paris, and Co-Social Media Editor of the SSCLE.
CRN Team McDonough, one of our new Tool Generation teams, is creating high-quality iPSC models with precise gene edits to study #Parkinson’sDisease.
Built for reproducibility — and to be shared widely across the field.
Follow along 👇
🔗 bit.ly/4tOFTpx
CRN Team McDonough, one of our new Tool Generation teams, is creating high-quality iPSC models with precise gene edits to study #Parkinson’sDisease.
Built for reproducibility — and to be shared widely across the field.
Follow along 👇
🔗 bit.ly/4tOFTpx
This week we introduce Stephan Knott, PhD Candidate in the Department of History at the University of Minnesota, and Social Media Editor of the SSCLE – which means he is, in part, responsible for the very series you are reading.
This week we introduce Stephan Knott, PhD Candidate in the Department of History at the University of Minnesota, and Social Media Editor of the SSCLE – which means he is, in part, responsible for the very series you are reading.
CRN Team Koob, one of our new Tool Generation teams, is developing full human gene replacement mouse models for #ParkinsonsDisease.
New models designed to better reflect human biology and support translational research.
More spotlights ahead 👇
🔗https://bit.ly/4ug5TuV
CRN Team Koob, one of our new Tool Generation teams, is developing full human gene replacement mouse models for #ParkinsonsDisease.
New models designed to better reflect human biology and support translational research.
More spotlights ahead 👇
🔗https://bit.ly/4ug5TuV
This week we introduce Joana Lencart, PhD Researcher at the Interdisciplinary Research Centre of Culture, Space and Memory (CITCEM) at the University of Porto.
This week we introduce Joana Lencart, PhD Researcher at the Interdisciplinary Research Centre of Culture, Space and Memory (CITCEM) at the University of Porto.
Paula Pinto Costa is Full Professor in the Department of History and Political and International Studies at the Faculty of Arts and Humanities, University of Porto.
Paula Pinto Costa is Full Professor in the Department of History and Political and International Studies at the Faculty of Arts and Humanities, University of Porto.